Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insider Buying at Gladstone Investment Corporation (GAIN)

According to SEC filings, the CEO of Gladstone Investment Corporation (NASDAQ:GAIN), David Gladstone, added to his position on June 15, buying 158,500 shares for a total cost of $1.25 million. Gladstone’s purchase gives him 526,973 shares total. Several hedge funds also added to their holdings in the first quarter. John Overdeck and David Siegel’s Two Sigma Advisors increased its position by 66% to 171,421 shares while D.E. Shaw increased its position by 248% to 84,784 shares. Joining them as large shareholders were Millennium Management with 76,866 shares, and Citadel Investment Group with 64,482 shares.

Gladstone Investment Corporation GAIN  logo

Studies show that insider trading can produce alpha. While there are many reasons why an insider would sell, there is only one reason why an insider would buy. Academic research shows that certain insider purchases have outperformed the market by an average of 7 percentage points per year. Another way to beat the market is by following the small-cap stock picks of hedge funds. Our research shows that the 15 most popular small-cap stocks among hedge funds have outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012. These stocks managed to return more than 142% over the ensuing 2.5+ years and outperformed the S&P 500 Index by over 84 percentage points.

Gladstone Investment Corporation (NASDAQ:GAIN) is a closed-ended business development company that makes equity and debt investments in established private businesses based in the United States, with the general goal of allocating 80% of its capital to debt securities and 20% of capital to equity securities. Because the U.S. economy has recovered, Gladstone has had a good three years. The size of Gladstone’s investment portfolio has increased form $226 million in March 2012 to $466 million in March 2015, while shares outstanding have increased by only 37% during that span. Because Gladstone’s portfolio size has increased, Gladstone’s income per common share has increased from $0.62 in 2012 to $0.75 in 2015, while its distribution per common share has increased from $0.61 in 2012 to $0.77 in 2015.

Powering Gladstone’s income growth is a recovering economy. The U.S. unemployment rate is now 5.5%, 2.7% below the unemployment rate in March 2012. With their jobs secure, consumers are spending more. The extra consumer spending is increasing the top and bottom lines of Gladstone’s portfolio companies and increasing Gladstone’s portfolio companies’ asset values. As the economy gathers strength, Gladstone’s net asset value (NAV) will continue to increase.

Also helping Gladstone is rising yields, which help Gladstone earn more from its variable debt investments. As of March 31, 2015, 79.9% of Gladstone’s debt portfolio securities are variable interest rate securities with a Libor Floor.

David Gladstone likely bought shares of Gladstone Investment Corporation (NASDAQ:GAIN) because the stock trades at a discount to the NAV. At its current price of $7.72 per share, Gain Investment Corporation trades at a 16% discount to its March 31 NAV of $9.18 per share. The discount to NAV adds a margin of safety to the stock. Another attractive property of Gladstone Investment Corporation is the monthly dividend of $0.0625, which gives the stock a dividend yield of 9.64%. Given the healthy economy and rising yields, Gladstone Investment Corporation’s dividend will likely continue to increase, making the stock that much more attractive to both insiders and outside investors alike.

Disclosure: None

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!